J&J Revitalizes Consumer Biz; Thrives On Pharma Strength In First Quarter
This article was originally published in The Pink Sheet Daily
Executive Summary
The healthcare conglomerate reported strong sales in the first quarter that were largely due to growth of its pharmaceutical business, but got an extra boost from the continued renewal of its consumer products portfolio.